drugset / Trial / NCT03824535
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Phase 2
Completed
15 enrolled
Andrei Iagaru
Boston University · collabCanary Foundation · collabUnited States Department of Defense · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with indeterminate lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.
Timeline
- Start
- 2019-02-04
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-FDG | Diagnostic / imaging agent | — | Intravenous |
| Subject | 18F-FSPG | Diagnostic / imaging agent | — | Intravenous |